Jing Lou
Co-Founder, Executive Chairman, CEO & PresidentDr. Jing Lou, M.D., Ph.D. is a Co-Founder of 3SBio Inc. and has been its Executive Chairman of the Board since April 1, 2012 and also serves as its Chief Executive Officer and President. Dr. Lou is Director at Numab Therapeutics AG from August 2022. Dr. Lou served as the Chief Executive Officer of Shenyang Sunshine since 2000. He joined Shenyang Sunshine as Director of Research and Development in 1995. Prior to that, Dr. Lou founded Lifegen, Inc., a Maryland Corporation and an investee company of Shenyang Sunshine, to optimize the manufacturing processes for EPIAO and TPIAO in the U.S. Dr. Lou has been an Executive Director at 3SBio Inc. since September 5, 2006. He served as a Director of Isotechnika Pharma Inc. from November 9, 2010 to July 29, 2011. Dr. Lou completed his post-doctoral study at the U.S. National Institutes of Health in 1995. He received his Ph.D. in Molecular and Cell Biology in February 1994 from Fordham University, where he researched interferon signal transduction of gene regulation and received his Bachelor of Medicine degree in clinical medicine from Shanghai Second Military Medical University in July 1985. He also obtained an Executive Master of Business Administration from China Europe International Business School in September 2008.
Positions
- Company Name3SBio Inc.Stock Code01530PositionCo-Founder, Executive Chairman, CEO & PresidentColleagues
- DSDongmei SuSenior VP & Executive Director
- XHXiang HeChief Financial Officer
- SKSiu Kuen LaiCompany Secretary
- YXYong XuGeneral Manager of Shenzhen Sciprogen Bio-pharmaceutical Technology Co., Ltd.
- TPTianruo PuIndependent Non-Executive Director
- HTHoi Ti YangIndependent Non-Executive Director
- JYJoo Yeow NgIndependent Non-Executive Director
